The Department of Health and Human Services Office of Inspector General (HHS-OIG), alongside key federal and state law enforcement partners, announced their participation in the National Healthcare Fraud Takedown, the largest such operation in US Department of Justice (DOJ) history. The coordinated action resulted in criminal charges against 324 defendants across 50 federal districts and 12 State Attorneys General’s Offices, with intended losses totaling more than $14.6 billion—more than double the previous record of $6 billion.
Among those charged were 96 licensed medical professionals, including doctors, nurse practitioners, and pharmacists, accused of participating in fraud schemes that exploited vulnerable patients and taxpayers. The DOJ announced the results on June 30, highlighting the sweeping scale of the effort, which involved dozens of federal and state agencies working together to identify and dismantle complex healthcare fraud networks.
As part of the operation, the government seized over $245 million in assets, including cash, luxury vehicles, and cryptocurrency. Additionally, the Centers for Medicare & Medicaid Services (CMS) reported preventing over $4 billion in fraudulent payments and suspending or revoking the billing privileges of 205 providers leading up to the Takedown. Civil enforcement actions included charges against 20 defendants for $14.2 million in alleged fraud and settlements with 106 others totaling $34.3 million.
The Takedown includes a variety of cases representing multiple healthcare fraud schemes. In Arizona and Nevada, seven defendants, including five medical professionals, were charged in a $1.1 billion scheme involving the unnecessary application of amniotic wound allografts, often to elderly hospice patients. The treatments were allegedly applied without coordination with patients’ doctors and sometimes to superficial or improperly treated wounds. Some defendants are accused of receiving millions in illegal kickbacks.
In another major case, 49 defendants were charged in connection with $1.17 billion in fraudulent Medicare claims involving telemedicine and genetic testing schemes. For instance, a Florida defendant allegedly used telemarketing campaigns to deceive Medicare beneficiaries, then submitted fraudulent claims for durable medical equipment and genetic tests. These cases reflect the Department’s continued focus on telemedicine-related fraud, including scams involving COVID-19 testing.
According to the press release, the Takedown also marked the launch of a new Healthcare Fraud Data Fusion Center, a collaborative effort among federal agencies to improve the detection of healthcare fraud. The center brings together data and expertise from multiple sources and uses advanced technologies, such as data analytics and cloud computing, to identify potential fraud more efficiently. This initiative supports broader federal efforts to improve coordination and reduce duplication across agencies.
Alongside the DOJ, HHS-OIG, FBI, DEA, and CMS, numerous other agencies participated in the enforcement action, including Homeland Security Investigations (HSI), IRS Criminal Investigation, Department of Veterans Affairs OIG, and the Medicaid Fraud Control Units of 20 states.
The following materials related to the June 30 announcement are available here:
You can access the press release here.
Compliance Perspective
Issue
Healthcare fraud, waste, and abuse continue to impact federal and state healthcare programs, affecting both patient care and program costs. The recent nationwide healthcare fraud takedown, which charged hundreds of defendants involved in schemes totaling billions of dollars, underscores the importance of strong compliance programs within healthcare organizations. Providers must maintain vigilant efforts to prevent fraudulent activities in order to protect patients, preserve public resources, and meet regulatory obligations.
Discussion Points
- Ensure your facility’s compliance and ethics program includes clear policies and procedures to prevent, detect, and respond to healthcare fraud. Regularly review and update these policies to stay current with new risks and ensure compliance with applicable laws and regulations.
- Provide ongoing education to all staff about fraud prevention, ethical billing practices, and the importance of reporting suspected fraud or abuse. Emphasize that compliance is everyone’s responsibility and that protections are in place for those who report concerns in good faith.
- Conduct periodic audits to assess adherence to compliance policies and to identify potential fraud or areas of concern. Use audit findings to support corrective actions and reinforce staff understanding of their responsibilities under the compliance program, including their duty to report any potential violations to their supervisor, the compliance and ethics officer, or via the anonymous hotline.
*This news alert has been prepared by Med-Net Concepts, Inc. for informational purposes only and is not intended to provide legal advice.*